Remove 2018 Remove Competition Remove Healthcare
article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled. Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline.

Pharma 105
article thumbnail

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity. Alex has a BSc in Human Genetics. References 1.

Medical 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

article thumbnail

How to Succeed as a Clinical Specialist in Medical Sales With Gina Torres

Evolve Your Success

Whether you’re a healthcare professional, an aspiring medical sales rep, or simply curious about this dynamic field, this episode is packed with motivation, industry knowledge, and career-changing insights! That’s a very it’s an extremely competitive space where there are other spaces and they may have no competitor.

article thumbnail

The importance of SDoH insights at the peak of healthcare consumerism

Clarify Health

As economic purchasing power and decision-making increasingly fall within the hands of patients, and as non-traditional healthcare providers, like Amazon and Walmart, push care into retail experiences, healthcare consumers are becoming more selective, and some may be more willing to “shop around” for health services.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. governmental healthcare organisations.

article thumbnail

What to expect in the new era of healthcare price transparency

Clarify Health

Healthcare price transparency continues to grow, with health insurers required to release cost-sharing estimates beginning in 2022. What’s new for healthcare price transparency in 2021 ? The American healthcare system is ushering in a new era of health cost transparency. Why is price transparency important in healthcare?